Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

February 2015 - FRMC

Department

News Connection
Diabetes Roadmap: SGLT-2 Inhibitors
02/18/2015
Diabetes is a major health problem with the incidence rate continuing to rise in the United States. 
Diabetes is a major health problem with the incidence rate continuing to rise in the United States. 
Diabetes is a major health...
02/18/2015
First Report Managed Care
Conference Insider
New RA Care Model Reduces Costs and Improves Quality
02/17/2015
Rheumatoid arthritis is largely associated with significant morbidity, mortality, and overall costs.
Rheumatoid arthritis is largely associated with significant morbidity, mortality, and overall costs.
Rheumatoid arthritis is largely...
02/17/2015
First Report Managed Care
Conference Insider
Dangers of Secondhand Marijuana Smoke
02/17/2015
According to the 2014 Surgeon General’s report on the consequences of smoking, secondhand tobacco smoke causes about 34,000 premature deaths from heart disease each year in the United States among nonsmokers.
According to the 2014 Surgeon General’s report on the consequences of smoking, secondhand tobacco smoke causes about 34,000 premature deaths from heart disease each year in the United States among nonsmokers.
According to the 2014 Surgeon...
02/17/2015
First Report Managed Care
Department
Literature Review: Plaque Psoriasis
02/18/2015
Psoriasis is a common chronic skin disease characterized by cutaneous inflammation and epidermal hyperproliferation.
Psoriasis is a common chronic skin disease characterized by cutaneous inflammation and epidermal hyperproliferation.
Psoriasis is a common chronic...
02/18/2015
First Report Managed Care
TNF Dose Reduction Safe, Effective, and Less Costly for Some RA Patients
02/17/2015
Tumor necrosis factor inhibitors are often used for the treatment of rheumatoid arthritis; but, they are associated with side effects, and are costly medications.
Tumor necrosis factor inhibitors are often used for the treatment of rheumatoid arthritis; but, they are associated with side effects, and are costly medications.
Tumor necrosis factor inhibitors...
02/17/2015
First Report Managed Care
Complication Risks During Delivery Low for Pregnant Women with CHD
02/17/2015
Labor, delivery, and the postpartum period are a time of increased arrhythmia and congestive heart failure incidence.
Labor, delivery, and the postpartum period are a time of increased arrhythmia and congestive heart failure incidence.
Labor, delivery, and the...
02/17/2015
First Report Managed Care
Stress Plays Role in Younger Women with CHD
02/17/2015
New research found that young women with stable coronary heart disease are more likely than men of the same age to develop reduced blood flow to the heart if they are under emotional stress but not physical stress.
New research found that young women with stable coronary heart disease are more likely than men of the same age to develop reduced blood flow to the heart if they are under emotional stress but not physical stress.
New research found that young...
02/17/2015
First Report Managed Care
The Economic Burden of an Increasingly Aging Population
02/17/2015
As the US population continues to age, questions arise regarding Medicare costs and implications for the federal budget.
As the US population continues to age, questions arise regarding Medicare costs and implications for the federal budget.
As the US population continues...
02/17/2015
First Report Managed Care

News

News
Study Finds Secukinumab Improves Quality of Life for Patients with Psoriasis
02/17/2015
Psoriatic arthritis (PsA) is associated with progressive pain, fatigue, disability, structural damage, and reduced health-related quality of life. Interluekin-17A antagonists are developing as a potential treatment option for PsA.
Psoriatic arthritis (PsA) is associated with progressive pain, fatigue, disability, structural damage, and reduced health-related quality of life. Interluekin-17A antagonists are developing as a potential treatment option for PsA.
Psoriatic arthritis (PsA) is...
02/17/2015
First Report Managed Care
News
Improvement of Disease Activity in Patients with PsA with Apremilast
02/17/2015
Boston—The results of a recent study indicated that apremilast demonstrated clinically meaningful improvements in psoriatic arthritis (PsA) disease activity measures that were sustained with continual treatment for 52 weeks. Improvements were...
Boston—The results of a recent study indicated that apremilast demonstrated clinically meaningful improvements in psoriatic arthritis (PsA) disease activity measures that were sustained with continual treatment for 52 weeks. Improvements were...
Boston—The results of a recent...
02/17/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Cigna Reports Cost Savings Associated With Fusing Medical, Drug, and Behavioral Benefits
01/07/2020
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach...
01/07/2020
First Report Managed Care
News
Foes of new health system more likely to vote Nov. 2
09/27/2010
09/27/2010
First Report Managed Care
Conference Insider
New Shingles Vaccine Cost-Effective, Cost-Saving Compared With Zostavax
05/31/2018
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP...
05/31/2018
First Report Managed Care
News
Jentadueto Approved for Type 2 Diabetes
01/31/2012
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug...
01/31/2012
First Report Managed Care
News
Value-Based Contracting Showing Greater Value for Care Provided, Innovative Opportunities
07/13/2015
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based...
07/13/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

February 2015 Volume 12 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement